Schedule 13G ownership disclosure

AKERO THERAPEUTICS INC

Common Stock · CUSIP: 00973Y108

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Wellington Management Group LLP

    Shares: 3,409,946.00 · Class: 4.3%

  • Wellington Group Holdings LLP

    Shares: 3,409,946.00 · Class: 4.3%

  • Wellington Investment Advisors Holdings LLP

    Shares: 3,409,946.00 · Class: 4.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-25-000279
Form type
SCHEDULE 13G/A
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Aug 12, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub